Clinical Trial Update: HOST - DAPT Duration According the Bleeding Risk [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating whether the duration of dual antiplatelet therapy should be tailored to bleeding risk in patients with coronary artery di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Infarction
• Stable Angina

Snippet

Sponsor: Seoul National University Hospital | Conditions: Coronary Artery Disease, Acute Myocardial Infarction | Phase 4 | Status: ACTIVE_NOT_RECRUITING